Showing results (31-40 of 96) with videos related to
Sort By:
Pageof 10
Atherosclerosis|September 1, 1982
Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjectsJ M Stewart, C J Packard, A R Lorimer, et al.British Journal of Pharmacology|May 1, 1974
The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in manW S Hillis, I Hutton, T D Lawrie, et al.Arteriosclerosis (Dallas, Tex.)|March 1, 1985
Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjectsJ Shepherd, M J Caslake, A R Lorimer, et al.Scottish Medical Journal|July 1, 1985
Haematocrit in patients attending a hypertension clinicG D Lowe, J Robertson, F G Dunn, et al.European Journal of Clinical Pharmacology|January 1, 1990
The effects of felodipine in angina pectorisA R Lorimer, P MacFarlane, S Pringle, et al.British Journal of Clinical Pharmacology|March 1, 1978
Standardized stress and hypertension: comparison of effect of propranolol and methyldopaF G Dunn, D I Melville, J V Jones, et al.British Heart Journal|November 1, 1976
Lipoprotein levels in apparently healthy men and women in the west of ScotlandJ S Jubb, A R Lorimer, V M Hawthorne, et al.Alimentary Pharmacology & Therapeutics|October 1, 1988
The effect of a long-acting somatostatin analogue on portal and systemic haemodynamics in cirrhosisS D Pringle, R F McKee, O J Garden, et al.Journal of the American College of Cardiology|May 1, 1989
Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertensionS D Pringle, P W Macfarlane, J H McKillop, et al.Postgraduate Medical Journal|January 1, 1976
Indications for beta-adrenoceptor blocking drugs in hypertensionA R Lorimer, J V Jones, B Clark, et al.Pageof 10